Thank you WTT for your very informative analysis
Some of the main takeaways from the original grant funding requirements were that the proponent's technology was already proven and could be currently tested by MESC and ANL, off take agreements ( or at least mou's) were in place, 50% project equity was available and the project would be ready for commercial scale production in 2026
E25 meets these requirements and DOE needs E25 to produce HPMSM to fulfill the battery manganese sulphate short fall in the US with very little being produced onshore currently
- Forums
- ASX - By Stock
- E25
- Ann: E25 HPMSM project selected for US$166M DoE Grant
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

Ann: E25 HPMSM project selected for US$166M DoE Grant, page-114
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
3 | 28857 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online